Introduction
Your body stores fat in two fundamentally different compartments with very different health implications. Visceral fat surrounds your abdominal organs and is the dangerous, metabolically active type linked to heart disease and diabetes. Subcutaneous fat sits just beneath your skin across your entire body and, in moderate amounts, is largely benign and physiologically necessary. A BIA smart scale measures both separately, giving you a complete fat distribution picture that a simple body fat percentage cannot provide. Understanding the difference between these two fat types helps you interpret your scale readings correctly and prioritise the right interventions.
Visceral Fat: The Metabolically Dangerous Type
Visceral adipose tissue (VAT) accounts for approximately 10-20% of total body fat in men and 5-8% in women with healthy body composition. Despite its relatively small proportion of total fat, its metabolic impact is disproportionately large. VAT cells are large, insulin-resistant, and highly lipolytic — they release fatty acids rapidly in response to stress hormones. Because VAT drains into the portal vein, these fatty acids flood the liver directly, driving hepatic insulin resistance, increasing VLDL production, and promoting triglyceride accumulation. VAT also secretes inflammatory cytokines including resistin and PAI-1 that increase cardiovascular risk. The key clinical measure is visceral fat area on CT scan — above 100 cm squared is elevated, above 160 cm squared is high risk — and BIA scales calibrate their 1-30 level scale to these thresholds.
Subcutaneous Fat: The Protective Type in Moderate Amounts
Subcutaneous fat is the fat you can pinch between your fingers — on your abdomen, thighs, hips, arms, and buttocks. Unlike visceral fat, subcutaneous fat drains into the systemic circulation rather than the portal vein, meaning its metabolic products do not hit the liver in concentrated form. Subcutaneous fat in the lower body (thighs and hips) is actually considered protective in metabolic studies — it acts as a metabolic buffer, capturing excess fatty acids that might otherwise contribute to visceral or ectopic fat deposition. Women naturally carry more subcutaneous fat than men (essential fat requirements for hormonal function, pregnancy support), and premenopausal women with predominantly lower-body subcutaneous fat distribution have significantly lower cardiovascular risk than men with equivalent total body fat. Subcutaneous fat becomes problematic only in excess, when total subcutaneous fat exceeds healthy ranges and extends into abdominal subcutaneous depots that behaviorally mimic visceral fat.
Interpreting Your Scale's Fat Distribution Data
When you step on a Hype Scale, you receive separate readings for visceral fat level and total body fat percentage. These two numbers together tell a far more complete story than either alone. Four interpretive scenarios:
- Low visceral fat (level 1-9) with moderate body fat: healthy distribution — subcutaneous fat predominates, low metabolic risk despite non-lean appearance
- Elevated visceral fat (level 10-14) with normal body fat: highest-risk pattern — appears lean externally but carries dangerous internal fat; prioritise aerobic exercise
- High visceral fat (level 15+) with high body fat: maximum intervention priority — both fat compartments need reduction through combined diet, exercise, and sleep improvement
- Low visceral fat with high body fat: predominantly subcutaneous distribution — lower immediate cardiometabolic risk; focus on overall fat reduction rather than visceral-specific interventions
Conclusion
The distinction between visceral and subcutaneous fat is one of the most clinically important concepts in body composition health. Your BIA scale's ability to measure both compartments separately means you can identify your specific fat distribution pattern, understand your actual cardiometabolic risk profile, and target your interventions appropriately. Visceral fat reduction through aerobic exercise and dietary improvement delivers the most health benefit per kg of fat lost. Tracking both metrics monthly provides the clearest picture of how your body composition is changing in response to your lifestyle.
References
- Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887. [Link]
- Fox CS, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39-48. [Link]
- Koster A, et al. Visceral adiposity and metabolic syndrome risk: MESA Study. Obesity. 2010. [Link]
- Snijder MB, et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes. Am J Clin Nutr. 2003;77(5):1192-1197. [Link]
- Shim U, et al. Utility of visceral fat level by BIA in metabolic syndrome prediction. Diabetes Metab J. 2020. [Link]
- WHO. Waist circumference and waist-hip ratio report. World Health Organization. 2008. [Link]